National Home Infusion Association

06/05/2026

Present at NHIA 2027 in San Diego!

Share your expertise with the field at the NHIA 2027 Annual Conference in San Diego, March 18–23. Proposals are open now; the submission deadline is July 17, 2026.

Learn more & submit: https://loom.ly/vJjbF50

06/03/2026

Managing policy adherence is one of the most challenging responsibilities a Designated Person faces.

NHIA's upcoming session on June 10, Leading with Clarity: Communication Strategies for Designated Persons, covers practical tools for identifying the root causes of staff resistance, communicating the "why" behind established policies, and building a culture of accountability without sacrificing team morale.

You will leave with communication strategies you can apply immediately in sterile compounding environments.

Save your seat: https://loom.ly/TZ80nc4

The Sterile Compounding educational series is supported through an educational grant from Wolters Kluwer.

06/03/2026

CMS has proposed replacing the 500mg billing units used for intravenous immune globulin (IVIG) with new HCPCS codes in 100mg or 200mg units, effective January 1, 2027.

NHIA strongly opposes the proposal as these changes would impose significant operational, administrative, reimbursement, and patient care burdens across the healthcare system with no clinical benefit or cost savings to justify them. Our comments to CMS ask for the proposal to be withdrawn or, at minimum, implementation delayed 18 months, with standardized units across IG products and prior-authorization crosswalks published before any change takes effect.

Read NHIA's full comments to CMS: https://loom.ly/eRlKPS0

Home infusion providers: submit your own comments to [email protected] before the deadline.

NHIA strongly opposes CMS’s proposed HCPCS coding and billing unit changes for immune globulin products, arguing that the changes would create significant administrative, operational, reimbursement, and patient care challenges without providing meaningful clinical or financial benefit.

06/01/2026

Join an NHIA Committee.

It's the best way to connect with the people across the country doing exactly what you do, and to put your experience to work shaping the education and advocacy the field depends on. Share what you know, learn from others, and build relationships that outlast any single project.

Committees now accepting 2026 applications:
Education (Clinical, Leadership, Nursing, Revenue Cycle, Sales & Marketing)
Clinical Practice
Membership Advisory
Quality and Standards
Sterile Compounding Practice
Medicare Contractor Advisory
Payer Advocacy and Relations

Applications are due June 5.

Learn more participate: https://loom.ly/EddWQvM

05/22/2026

Catch the Recording: CMS has proposed major HCPCS coding changes for immune globulin (Ig) products effective January 1, 2027.

The proposal would replace many existing 500 mg billing unit codes with new manufacturer-specific codes using smaller 100 mg or 200 mg billing units.

These changes could create significant operational challenges, including system updates, claims complexity, unit conversion risks, payer adjudication changes, and staff education needs across providers, manufacturers, and payers.

The recording provides an overview of the proposed changes and discussion of the potential impact on home infusion providers and other industry stakeholders.

Watch the recording: https://loom.ly/Gl7iXxw

05/19/2026

Explore the Year's Best Education on Your Schedule

Access the full NHIA 2026 conference education—worth more than 40 CEs—or just choose from a specific education track: Clinical, Leadership, Nursing, Revenue Cycle, Sales & Marketing, or Sterile Compounding.

All recordings: $499 | 1 track: $149

View the education & purchase access: https://loom.ly/-k4SPmU

05/18/2026

Join NHIA for an open-access webinar providing an overview CMS' proposed HCPCs coding changes and a discussion of the potential impact on home infusion providers and other industry stakeholders.

CMS has proposed major HCPCS coding changes for immune globulin (Ig) products effective January 1, 2027. The proposal would replace many existing 500 mg billing unit codes with new manufacturer-specific codes using smaller 100 mg or 200 mg billing units.

These changes could create significant operational challenges, including system updates, claims complexity, unit conversion risks, payer adjudication changes, and staff education needs across providers, manufacturers, and payers.

Learn more & register: https://loom.ly/-lHlSdc

05/06/2026

NHIF Contributes to AJHP Publication on HPN Readmissions

The American Journal of Health-System Pharmacy published an article by Alexandre Ivanov, et al. The article, “Home Parenteral Nutrition and 30-Day Hospital Readmission: A Descriptive Study,” found HPN-related hospital readmissions were most likely to occur in the first 14 days of the patient being at home. Researchers conclude that earlier readmissions highlight the importance of the care transition process.

Read the article: https://loom.ly/ZxkpAwY

05/06/2026

The home infusion market is evolving rapidly, bringing new growth opportunities alongside increased operational and regulatory complexity. Providers are being asked to manage higher-value claims, navigate stricter payer requirements, and maintain compliance—all while modernizing systems and exploring new technologies like AI.

Join NHIA and Prochant for a webinar where we'll focus on how to scale effectively during this period of transition. We’ll cover how to approach system changes without disrupting workflows, where AI can drive meaningful efficiency and accuracy, and how to strengthen compliance processes to meet rising payer scrutiny.

Learn more & register: https://loom.ly/jyXRBAY

Speakers:
Cynde Derryberry - Director of Revenue Cycle, Nutrishare
Pamela McIntyre - Founder and Owner, Expert Infusion Nurse Consulting
Paula Roth - Executive Vice President of Pharmacy Operations, Prochant